Brief: BioAtla Q2 Net Income USD -18.711 Million
07/08/2025 21:05
Aug 07 (Reuters) - BioAtla Q2 operating expenses USD 18.647 million. Q2 operating income USD -18.647 million
Recent news on Bioatla
See all newsBrief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM